These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9851289)

  • 1. Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate.
    Lewis DF; Eddershaw PJ; Dickins M; Tarbit MH; Goldfarb PS
    Chem Biol Interact; 1998 Oct; 115(3):175-99. PubMed ID: 9851289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the recognition of mammalian microsomal cytochrome P450 substrates and their characteristics: towards the prediction of human p450 substrate specificity and metabolism.
    Lewis DF
    Biochem Pharmacol; 2000 Aug; 60(3):293-306. PubMed ID: 10856424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P450BM-3; a tale of two domains--or is it three?
    Peterson JA; Sevrioukova I; Truan G; Graham-Lorence SE
    Steroids; 1997 Jan; 62(1):117-23. PubMed ID: 9029725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compound lipophilicity for substrate binding to human P450s in drug metabolism.
    Lewis DF; Jacobs MN; Dickins M
    Drug Discov Today; 2004 Jun; 9(12):530-7. PubMed ID: 15183161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Speculations on the substrate structure-activity relationship (SSAR) of cytochrome P450 enzymes.
    Smith DA; Jones BC
    Biochem Pharmacol; 1992 Dec; 44(11):2089-98. PubMed ID: 1472073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 substrate specificities, substrate structural templates and enzyme active site geometries.
    Lewis DF; Dickins M; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Drug Metabol Drug Interact; 1999; 15(1):1-49. PubMed ID: 10707112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the estimation of binding affinity (deltaGbind) for human P450 substrates (based on Km and KD values).
    Lewis DF
    Curr Drug Metab; 2003 Oct; 4(5):331-40. PubMed ID: 14529365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural models for cytochrome P450-mediated catalysis.
    Lewis DF
    ScientificWorldJournal; 2003 Jun; 3():536-45. PubMed ID: 12847303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational states of cytochrome P450cam revealed by trapping of synthetic molecular wires.
    Hays AM; Dunn AR; Chiu R; Gray HB; Stout CD; Goodin DB
    J Mol Biol; 2004 Nov; 344(2):455-69. PubMed ID: 15522298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular orbital-generated QSARs in a homologous series of alkoxyresorufins and studies of their interactive docking with P450s.
    Lewis DF; Lake BG; Parke DV
    Xenobiotica; 1995 Dec; 25(12):1355-69. PubMed ID: 8719910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450.
    Poulos TL
    Curr Opin Struct Biol; 1995 Dec; 5(6):767-74. PubMed ID: 8749364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for communality in the primary determinants of CYP74 catalysis and of structural similarities between CYP74 and classical mammalian P450 enzymes.
    Hughes RK; Yousafzai FK; Ashton R; Chechetkin IR; Fairhurst SA; Hamberg M; Casey R
    Proteins; 2008 Sep; 72(4):1199-211. PubMed ID: 18338380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Key substrate recognition residues in the active site of a plant cytochrome P450, CYP73A1. Homology guided site-directed mutagenesis.
    Schoch GA; Attias R; Le Ret M; Werck-Reichhart D
    Eur J Biochem; 2003 Sep; 270(18):3684-95. PubMed ID: 12950252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in cytochrome P450 active site modeling.
    Kemp CA; Maréchal JD; Sutcliffe MJ
    Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of distinct ligand binding sites for cytochrome P450 3A4.
    Hosea NA; Miller GP; Guengerich FP
    Biochemistry; 2000 May; 39(20):5929-39. PubMed ID: 10821664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From the Cover: Structural Determinants of the Position of 2,3',4,4',5-Pentachlorobiphenyl (CB118) Hydroxylation by Mammalian Cytochrome P450 Monooxygenases.
    Mise S; Haga Y; Itoh T; Kato A; Fukuda I; Goto E; Yamamoto K; Yabu M; Matsumura C; Nakano T; Sakaki T; Inui H
    Toxicol Sci; 2016 Aug; 152(2):340-8. PubMed ID: 27208082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 networks in chemical space.
    Lee S; Kim D
    Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.